Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aethics was a private Colorado-based consumer health and wellness company focused on hemp-derived CBD products for active lifestyle and sports recovery customers. The company marketed a seed-to-sale portfolio that included CBD oils, topical lotions and rubs, gummies, beverages, and pet wellness products, emphasizing in-house cultivation, processing, and product quality. Its positioning was closer to wellness retail than to a traditional biotech or pharmaceutical developer, and there is no evidence of a drug-development pipeline or clinical-stage therapeutic programs. Available business databases indicate the company launched around 2018, operated from Lakewood, Colorado, raised private funding, and was later reported as out of business. For biotech analysts, Aethics is best understood as a cannabinoid wellness brand rather than a therapeutic life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aethics.